Skip to content

Effects of Caffeine on Agility in Amateur Soccer Players

Effects of Caffeine on Physical and Perceptual-cognitive Components of Agility in Amateur Soccer Players

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07844122
Enrollment
16
Registered
2026-09-28
Start date
2024-10-21
Completion date
2024-12-20
Last updated
2026-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult Male

Keywords

Caffeine, Athletes, Exercise, Muscle Strength, Psychomotor Performance

Brief summary

This randomized, double-blind, placebo-controlled crossover clinical trial aims to investigate the acute effects of caffeine supplementation on motor and perceptual-cognitive components of agility performance in male amateur soccer players. The main questions are: i) Does acute caffeine supplementation improve motor performance, including countermovement jump height, drop-jump reactive strength, and planned agility? ii) Does acute caffeine supplementation improve perceptual-cognitive performance during reactive agility tasks involving light and human stimuli? Participants will complete two experimental conditions in randomized order, receiving either 300 mg of caffeine (\ 3.7 miligrams/kilograms of body mass) or placebo pills. Following ingestion, participants will perform countermovement and drop jumps and three Y-shaped agility tests assessing planned agility, reactive agility to a light stimulus, and reactive agility to a human stimulus.

Detailed description

Caffeine supplementation was investigated for its potential to differentially affect motor and perceptual-cognitive aspects of performance in athletes. Participants were recruited from amateur soccer clubs competing in the third to fifth tiers of the Slovak league system and fifth to sixth tiers of the Austrian league system. A pre-selection questionnaire was used to assess relevant demographic, sporting, health, injury, and habitual caffeine consumption characteristics. Players with habitual caffeine intake above 400 miligrams/day were excluded. A familiarization session was conducted approximately one week before the experimental measurements to practice the procedures and reduce learning effects. The intervention consisted of a single 300 milligrams caffeine dose, corresponding to approximately 3.7 miligrams/kilograms of body mass. The placebo consisted of potato starch. Caffeine and placebo capsules were visually identical. Condition order was determined by simple randomization using an independent online randomization generator, and the investigator responsible for randomization was not involved in testing. Participants and testers remained unaware of the assigned condition. Participants were instructed to maintain their usual training regimen, abstain from caffeine-containing products for at least 24 hours before testing, and avoid intense physical activity on the preceding day. The two experimental sessions were conducted seven days apart, during the same period of the soccer season and at the same time of day to reduce potential effects of recovery and circadian variation. Diet, fluid intake, and sleep were not standardized. After capsule ingestion, participants completed a standardized dynamic warm-up involving aerobic activation, lunges, dynamic stretching, and countermovement jumps. Testing subsequently assessed explosive lower-limb performance and agility under controlled laboratory and field conditions. The agility assessment used a Y-shaped setup and distinguished between a predetermined change-of-direction task and reactive tasks requiring a response to either a visual light stimulus or a live human stimulus. The human-stimulus condition was designed to introduce a greater perceptual and decision-making component than the planned condition. Participants were required to perceive the tester's movement and rapidly select the appropriate alternative direction. Reactive trials were repeated when predefined technical errors, incorrect responses, slips, or other invalid performances occurred. The experimental procedures were completed within a short testing window following supplementation to correspond with the expected onset of caffeine's acute physiological effects. The fixed testing sequence was maintained across both experimental conditions to ensure consistency between visits. The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Faculty of Physical Education and Sport, Comenius University in Bratislava (Approval Number 15/2024). All participants provided written informed consent before participation.

Interventions

DIETARY_SUPPLEMENTCaffeine 300 MG

Supplementation was administered as caffeine capsules (Scitec Nutrition Caffeine, 100 milligrams per capsule). Subjects received 300 milligrams of caffeine, which represented an individual dose ranging from 3.16 to 4.44 milligrams/kilograms of body mass.

DIETARY_SUPPLEMENTPlacebo

Supplementation was administered as placebo capsules filled with potato starch. The capsules were visually identical, and neither the testers nor the participants were aware of the assigned condition.

Sponsors

Comenius University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

randomized, double-blind, placebo-controlled crossover study model

Eligibility

Sex/Gender
MALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Active male amateur soccer players competing in Slovakian 3rd to 6th tier-league and Austrian 4th to 7th tier-league, * Regular participation in soccer training and competition, * No current health restrictions preventing participation in maximal physical testing * Provided written informed consent

Exclusion criteria

* Goalkeepers * Current or recent musculoskeletal injury affecting physical performance * Acute illness at the time of testing * Cardiovascular or neurological disorders * Visual impairment affecting performance of the experimental tasks * Significant sleep disorders * Habitual caffeine consumption exceeding 400 mg/day * Failure to complete both experimental sessions

Design outcomes

Primary

MeasureTime frameDescription
Planned Agility40 minutes after caffeine/placebo ingestionThe running course was divided into two sections. The first section consisted of a 5 meter linear sprint from a two-point starting position. At the end of the linear section, two cones positioned 1-meter apart marked the change-of-direction area. The participant was instructed by the tester to change the direction of sprinting by cutting at a 45° angle to either the left or right side. The primary outcome measure was the fastest trial completion time, recorded in seconds using a photocell timing system. Timing commenced when the participant crossed the starting gate and ended when the participant crossed the designated gate at the end of course.
Reactive Agility45 minutes after caffeine/placebo ingestionThe running course was divided into two sections. The first section consisted of a 5 meter linear sprint from a two-point starting position. At the end of the linear section, two cones positioned 1-meter apart marked the change-of-direction area. The participant was instructed by the tester to change the direction of sprinting according to the a) light sensor, b) human movement, by cutting at a 45° angle to either the left or right side. 1. Light sensor showed green arrow of dedicated change-of-direction. This stimulus occured 500 milliseconds after crossing the starting gate. 2. Human tester executed movement to the side when participants were 2.5 meters apart from starting gate. Participants were reacting by the execution of change-of-direction to the opposite side as human tester. The outcome was the fastest completion time, recorded in seconds using a photocell timing system.

Secondary

MeasureTime frameDescription
Countermovement jump30 minutes after caffeine/placebo ingestionAssessment of vertical power production by the lower limbs, evaluated as maximum countermovement jump height in centimeters.
Drop jump 3035 minutes after caffeine/placebo ingestionAssessment of reactive strength of the lower limbs, evaluated as the maximum reactive strength index (RSI) calculated from flight time and contact time during a drop jump from a 30 centimeter box.

Countries

Slovakia

Contacts

PRINCIPAL_INVESTIGATORFilip Skala, PhD.

Comenius University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 29, 2026